
Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
Esperion, announced that John Harlow will join the company as Chief Commercial Officer, effective November 17, 2025. In his new role, Mr. Harlow will become

Esperion, announced that John Harlow will join the company as Chief Commercial Officer, effective November 17, 2025. In his new role, Mr. Harlow will become

CQ Medical has announced the appointment of Michael Galbus as its Chief Executive Officer. Michael previously served as the company’s Chief Operating Officer, where he

PBS Biotech, a leading provider of innovative single-use bioreactor systems and bioprocess development services, has announced the appointment of Martin Simonetti as Chief Executive Officer,

Kaigene Inc., a biotechnology company based in the United States and focused on developing next-generation antibody therapies for autoimmune disorders, has announced an exclusive global

On November 4, 2025, Sky Labs announced that it has received investment from OMRON Ventures, which is part of the Omron Group and based in

Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,

WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers across Canada with high quality technology and services that significantly

Augmented Reality Glasses Purpose-Built for the Medical Technology Industry MDIC Medical XR Summit – Snke OS GmbH has announced the unveiling of SnkeXR, the first medical grade, open

Sophie Lamle brings over 20 years of experience in the pharmaceutical industry, leading innovation, clinical development, and strategic transformation. LEO Pharma, a leader in medical

Industry leaders join forces to bring advanced AI capabilities to dental technology platforms — redefining patient care, clinical efficiency, and practice performance worldwide Henry Schein

Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule Takeda announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study

Imagine walking into a hospital floor in 2026 and seeing an AI assistant reviewing imaging scans, smart wearable rings relaying real-time health data, and remote